OnFolio Holdings Inc. (ONFO) Announces Pricing of $13.7 Million Initial Public Offering and Nasdaq...

Nice work by EF Hutton. We like this business model. Similar to old school incubator, but they acquire rather than invest and...
Dr John Fahy UCSF

Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...

VERU Inc. (VERU) $24. High Risk, Minimal Reward?

Pre-FDA Approval Play. The Shares Are Now in the Hands of Fast Money Traders. You Can't Kiss all the...

Adding Alkaline Water (WTER) to 2022 Beverage Watch List at $0.46, More Names Coming.

The Alkaline Water Company (WTER). Identifies $15 Million in Cost Savings and Margin Enhancements. With nearly $200 million...

What is NAC (N-Acetyl-L-Cysteine)? (Dr Eric Berg)

https://youtu.be/oPdGOrqTfhA What is NAC good for? (and How Much to Take?)

Chula Vista Scamster Gets Pinched

Great detective work by the SEC on this. If you ever wonder how/why your stock or stock you're following drops from $1.00...

Revive Therapeutics (RVVTF) Enters the Danger Zone.

What Danger You Ask? Danger #1, the FDA doesn't like the data, and you own the stock.
Provention Bio

Adding Provention Bio (PRVB) $4.60 to 2022 Biotech Watch List.

This is in our 'Stocks we Hope to Double' Watch List. LIVE QUOTE
Anoop Bhatia

AI and Machine Learning Start-Up Nowigence (NWGO) Announces Deal With EquiPPP Technologies (NSE: EQIPPP).

Nowigence CEO Anoop Bhatia was voted most innovative AI NLP Company CEO 2020.With over two decades in various GE companies across different...

Bill Hwang Had $20 Billion, Then Lost It All in Two Days (Bloomberg).

With all the news on leveraged Bitcoin blowups being reported, let's not forget leverage can blowup an Equity portfolio too. Forgotten in...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!